Back to top

biotechs: Archive

Zacks Equity Research

Novavax Clinches $60M Defense Contract for Coronavirus Vaccine

Novavax (NVAX) secures a $60-million pact from the US Department of Defense to manufacture its COVID-19 vaccine candidate, NVX-CoV2373.

AZN MRNA NVAX EBS

Sweta Killa

ETFs Under $20 From 5 Hottest Zones

Let us dig into some of the ETFs that are below $20 and are from the hottest areas currently. These low-priced ETFs could lead to huge gains in the coming months.

SDIV IEZ SILJ KBWD GNOM

Zacks Equity Research

Gilead's Rating Upgraded on Potential Coronavirus Drug Sales

Gilead (GILD) rides high on potential sales from its experimental coronavirus treatment, remdesivir, and collaboration with Arcus.

GILD GSK GLPG RCUS

Kinjel Shah

Trump Picks 5 Coronavirus Vaccine Candidates Per NYT Report

The candidates belong to five companies, Moderna, AstraZeneca, J&J, Merck and Pfizer.

JNJ AZN PFE MRK MRNA

Sweta Jaiswal, FRM

How Are Biotech ETFs Reacting to Coronavirus Treatment News?

Here we take a look at how the latest updates on drugs, antibody therapies and vaccines targeted at winning the coronavirus battle can affect biotech ETFs.

GILD LLY IBB XBI BBH FBT ARKG

Zacks Equity Research

Will Translate Bio Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor of Translate Bio

TBIO

Zacks Equity Research

Biotech Stock Roundup: GILD's Coronavirus Drug Update, NTLA-REGN Deal & More

The biotech sector remains in focus with updates on coronavirus treatments and presentations at ASCO.

IRWD REGN GILD ABIO NTLA PHAS

Kinjel Shah

Boost Portfolio Gains With These 6 Low Price-to-Book Stocks

Though price-to-earnings and price-to-sales are the first choices, P/B ratio is also a convenient tool for identifying valuable stocks.

BIIB CSIQ ADS GPK CLS VST

Sweta Jaiswal, FRM

These ETF Areas Make Great Investment Choices in June

Here we highlight some ETF areas that will make interesting investment options for investors amid the coronavirus crisis.

IBB XBI BBH JETS IBUY BOTZ SKYY CLIX IRBO CLOU

Sweta Killa

4 Best ETF Charts of Q1 Earnings

Below are four ETFs that buoyed up on strong earnings results.

MSFT IBM AMZN SPY GOOGL ITB IBUY BBC WCLD

Zacks Equity Research

Myovant Eyes Relugolix Combo Approval for Uterine Fibroids

Myovant (MYOV) submits a regulatory application with the FDA seeking approval for oral relugolix combination regimen as a treatment for heavy menstrual bleeding associated with uterine fibroids.

JNJ ABBV MYOV TAK

Zacks Equity Research

FDA Okays AVEO's NDA Filing for Treating Renal Cell Carcinoma

AVEO's new drug application submission for tivozanib as a treatment of relapsed or refractory renal cell carcinoma gets acceptance from the FDA. A decision is expected on Mar 31, 2021.

AZN BMY BAYRY AVEO

Sweta Killa

U.S. Outperforms YTD: 6 Top-Ranked ETF Winners

Wall Street has staged a comeback since late March, leaving behind the rest of the world.

IBB QQQ JKE IGV FDN WCLD

Zacks Equity Research

Gilead Down on Mixed Results From Coronavirus Drug Remdesivir

Gilead's (GILD) shares decline on mixed results from a late-stage study on coronavirus drug.

ALXN RHHBY GILD INCY

Zacks Equity Research

Regeneron Expands Deal With Intellia for Hemophilia Treatments

Regeneron (REGN) expands partnership with Intellia Therapeutics to co-develop potential hemophilia A and B treatments.

REGN SNY GILD NTLA

Kinjel Shah

Coronavirus Treatment Search Still on, Lilly, Gilead Give Updates

Lilly (LLY) begins phase I study on a potential antibody therapy to treat COVID-19. Gilead (GILD) announces mixed results from the second phase III study on remdesivir in patients with moderate COVID-19.

REGN PFE GILD MRNA LLY GSK VIR

Zacks Equity Research

Implied Volatility Surging for Intec Pharma (NTEC) Stock Options

Investors need to pay close attention to Intec Pharma (NTEC) stock based on the movements in the options market lately.

NTEC

Zacks Equity Research

Do Options Traders Know Something About Myovant (MYOV) Stock We Don't?

Investors need to pay close attention to Myovant (MYOV) stock based on the movements in the options market lately.

MYOV

Benjamin Rains

Find Strong Buy Stocks for the Coronavirus Market Rally with this Screener

Zacks Rank #1 (Strong Buy) stocks outperform the market in both good and bad times. However, there are over 200 stocks that earn a Zacks Rank #1 at any given time...

MRSN CODX BGS

Benjamin Rains

3 Strong Pharmaceutical and Biotech Stocks to Buy for Coronavirus Immunity

Let's dive into three large-cap pharmaceutical and biotech stocks that appear set to grow during the pandemic-induced downturn and the eventual recovery...

PFE MRK LLY VRTX ABBV CRSP

Panel Of Zacks Experts

Top Stock Picks for Week of June 1, 2020

Two Zacks Strong Buy Stocks in Focus.

BJ LLY

Swayta Shah

Buy These 5 Stocks With Impressive Sales Growth Right Away

Sales growth can be considered by investors as a reliable metric for selecting profitable stocks amid the challenging operating backdrop.

CPB BMY INFO VST KDP

Zacks Equity Research

Implied Volatility Surging for AVEO Pharmaceuticals (AVEO) Stock Options

Investors need to pay close attention to AVEO Pharmaceuticals (AVEO) stock based on the movements in the options market lately.

AVEO

Zacks Equity Research

Implied Volatility Surging for Nabriva (NBRV) Stock Options

Investors need to pay close attention to Nabriva (NBRV) stock based on the movements in the options market lately.

NBRV

Tirthankar Chakraborty

5 Top Stocks Up 100%+ in May With More Room to Run

Reopening of the economy, vaccine hopes and stimulus measures helped Wall Street climb north in May and squash the old adage "sell in May and go away."

MRK MRNA NVAX CBAY EFOI MVIS ALRN MRSN